FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
The Seaver Autism Center for Research and Treatment - Assessment Core
Sponsor: Autism Science Foundation
This observational or N/A phase trial investigates Autism Spectrum Disorder and FOXP1 and is currently actively recruiting participants. Autism Science Foundation leads this study, which shows 15 recorded versions since 2016 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
15 versions recorded-
May 2025 — Present [monthly]
Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
May 2023 — May 2024 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Jun 2022 — May 2023 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
Feb 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Apr 2020 — Oct 2020 [monthly]
Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting
-
Dec 2019 — Mar 2020 [monthly]
Recruiting
-
Nov 2018 — Dec 2019 [monthly]
Recruiting
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Autism Science Foundation
- Icahn School of Medicine at Mount Sinai
- Research Foundation for Mental Hygiene, Inc.
- The Seaver Foundation
For direct contact, visit the study record on ClinicalTrials.gov .